Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 7 Neoplasms by Histologic Type 3 Neoplasms 3 Gastro-enteropancreatic neuroendocrine tumor 3 Neuroendocrine Tumors 2 Lymphoproliferative Disorders 2 Lymphoma, Non-Hodgkin 2 Lymphoma 2 Lymphatic Diseases 2 Immune System Diseases 2 Digestive System Neoplasms 2 AIDS-Related Complex 2 Urogenital Neoplasms 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumors 1 Recurrence 1 Prostatic Diseases 1 Prostate Cancer Metastatic 1 Pheochromocytoma 1 Paraganglioma 1 Pancreatic Neoplasms 1 Pancreatic Diseases 1 Neuroectodermal Tumors 1 Neoplasms, Nerve Tissue 1 Neoplasms, Germ Cell and Embryonal 1 Neoplasms by Site 1 Metastatic Neuroendocrine Prostate Cancer 1 Metastatic Castration-resistant Prostate Cancer (mCRPC) 1 Metastatic Castration-Resistant Prostate Cancer 1

Interventions

pembrolizumab 7 lenvatinib 3 apatinib 3 Magnetic Resonance Spectroscopy 3 Imatinib Mesylate 3 Carboplatin 3 gallium 68 PSMA-11 2 Specimen Handling 2 Protons 2 Nivolumab 2 Epirubicin 2 Cisplatin 2 Axitinib 2 4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 2 3-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2 tislelizumab 1 regorafenib 1 enfortumab vedotin 1 cabozantinib 1 avelumab 1 anlotinib 1 amivantamab 1 abemaciclib 1 Tretinoin 1 Trastuzumab 1 Tablets 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sunitinib 1 Standard of Care 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Adenoid Cystic × Lutetium × Clear all

NCT06199453 2025-02-10

LuRM_ACC/2023

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Withdrawn

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡